Corrigendum to “Feasibility of stereotactic radiotherapy with pembrolizumab in patients with deficient mismatch repair/microsatellite unstable metastatic colorectal cancer”

ESMO Gastrointestinal Oncology 2026 Open access

Read full text
Authors: Annalice Gandini, Valentino Martelli, Liliana Belgioia, S. Puglisi, M. Cremante, V. Murianni, Alessandra Damassi, Chiara Pirrone, F. Catalano, Maria Attilia Grassi, Lucia Trevisan, Stefano Vagge
+9 more V. Andretta, Serafina Mammoliti, D. Comandini, G. Fornarini, A. Pessino, A. Pastorino, S. Sciallero, Alberto Puccini, A.F. Sobrero
DOI: 10.1016/j.esmogo.2025.100279
Cited by: 0

Abstract

The authors regret that in the original publication it was not clear that this study was conducted as a compassionate use clinical trial. In the “Study design and treatment” subheading of the Patients and Methods section, the correct statement should read as follows:

Fields of Study & Subjects

Genetic factors in colorectal cancer Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies

Publication details

Journal / source
ESMO Gastrointestinal Oncology
Volume
11
Pages
100279–100279
Publication date
6 January 2026
Language
EN